Inhibition of FOXM1 Leads to Suppression of Cell Proliferation, Migration, and Invasion Through AXL/eEF2 Kinase Signaling and Induces Apoptosis and Ferroptosis in GBM Cells
International Journal of Molecular Sciences · 15.07.2025 · 26 (14) · 6792
DOI: 10.3390/ijms26146792 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.07.2025. Verfasst von Ezgi Biltekin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Forkhead Box Protein M1, Apoptosis, Glioblastoma, Ferroptosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Houston Methodist Research Institute Cancer Center.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is an aggressive and molecularly heterogeneous brain cancer with a poor prognosis. Despite advancements in standard-of-care therapies, including surgery, radiotherapy, and temozolomide (TMZ), the median survival remains approximately 15 months, with a 5-year survival rate of less than 10%. We and others have demonstrated that FOXM1 is a critical oncogenic driver of GBM cell proliferation. However, the role of FOXM1 and its interaction with other oncogenic signaling pathways in GBM remains incompletely understood. In this study, we identified FOXM1, AXL, and eEF2K as highly upregulated oncogenes in GBM patient tumors. We demonstrated, for the first time, that FOXM1 directly interacts with AXL and eEF2K, regulating their expression and promoting GBM cell proliferation, migration, and invasion. Knockdown of these genes disrupted cell proliferation, spheroid formation, migration, and invasion, and induced apoptosis and ferroptosis. Additionally, inhibiting the FOXM1–AXL/eEF2K signaling axis sensitized GBM cells to TMZ, further enhancing apoptotic and ferroptotic responses. These findings highlight the critical role of the FOXM1–AXL/eEF2K signaling pathway in GBM progression and suggest that targeting this axis may offer a novel multitargeted therapeutic strategy in GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
- Department of Biomedical Engineering, University of Houston, Houston, TX 77004, USA.
ORCID-Profile: Ezgi Biltekin, Yasemin M Akay, Metin Akay
Förderung
- Houston Methodist Research Institute Cancer Center
Zitieren
APA
Biltekin, E., Kahraman, N., Gul, O. A., Akay, Y. M., Akay, M., & Ozpolat, B. (2025). Inhibition of FOXM1 Leads to Suppression of Cell Proliferation, Migration, and Invasion Through AXL/eEF2 Kinase Signaling and Induces Apoptosis and Ferroptosis in GBM Cells. International Journal of Molecular Sciences, 26(14), 6792. https://doi.org/10.3390/ijms26146792
Vancouver
Biltekin E, Kahraman N, Gul OA, Akay YM, Akay M, Ozpolat B. Inhibition of FOXM1 Leads to Suppression of Cell Proliferation, Migration, and Invasion Through AXL/eEF2 Kinase Signaling and Induces Apoptosis and Ferroptosis in GBM Cells. International Journal of Molecular Sciences. 2025;26(14):6792. doi:10.3390/ijms26146792
BibTeX
@article{Biltekin2025,
author = {Biltekin, Ezgi and Kahraman, Nermin and Gul, Ogun Ali and Akay, Yasemin M and Akay, Metin and Ozpolat, Bulent},
title = {Inhibition of FOXM1 Leads to Suppression of Cell Proliferation, Migration, and Invasion Through AXL/eEF2 Kinase Signaling and Induces Apoptosis and Ferroptosis in GBM Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {14},
pages = {6792},
doi = {10.3390/ijms26146792}
}
EUVIMED